CSIMarket
 


Zoetis Inc   (ZTS)
Other Ticker:  
 


Zoetis Inc's ROI from its second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Zoetis Inc's ROI in the second quarter of 2024?
Zoetis Inc achieved a return on average invested assets (ROI) of 18.86 % in its second quarter of 2024, which is below Zoetis Inc's average return on investment, which stands at 22.3%.

ROI fell compared to the first quarter of 2024, despite the net income growth of 4.17% from the first quarter of 2024.

Within the Healthcare sector 28 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2024 quarter, so far to 245, from total ROI ranking in the first quarter of 2024 at 270.

Definition and Formula of Return on Investment


Return On Investment (Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
Y / Y Investment Change TTM 7.16 % 9.29 % 10.44 % 8.15 % 1.04 %
Y / Y Net Income Change TTM 6.02 % 15.47 % 54.25 % 115.42 % 317.58 %
Investment (TTM) in Millions 12,362 12,433 12,391 12,494 11,976
Return On Investment (TTM) 18.86 % 19.38 % 19.22 % 18.95 % 19.06 %
ZTS's Overall Ranking # 245 # 270 # 308 # 353 # 373
Seq. Investment Change TTM 0.78 % 1.23 % 1.32 % 3.67 % 2.79 %
Seq. Net Income Change TTM -1.93 % 2.05 % 2.77 % 3.08 % 6.82 %
Net Income (TTM) in Millions 2,342 2,388 2,340 2,277 2,209




Return On Investment ZTS's Ranking
Within: No.
Industry # 12
Sector # 29
Overall # 245

Return On Investment Statistics
High Average Low
43.45 %
22.3 %
12.73 %
(Oct 01 2017)   (Mar 31 2018)







Financial Statements
Zoetis Inc's II. Quarter Investments $ 12,362 Millions ZTS's Balance sheet
Zoetis Inc's II. Quarter Income $ 624 Millions Quarterly ZTS's Income Statement
ZTS's Income by Division See ZTS's Income by Division


ZTS Annual Return On Investment (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Total Investments in Millions 12,391 11,756 12,104 11,443 9,575
Y / Y Investment Growth 5.4 % -2.88 % 5.78 % 19.51 % 0.22 %
Net Income in Millions 2,340 2,111 2,034 1,636 1,500
Y / Y Net Income Growth 10.85 % 3.79 % 24.33 % 9.07 % 5.34 %
Annual Return On Investment 18.88 % 17.96 % 16.8 % 14.3 % 15.67 %


Annual Roi Comment
In the fiscal year 2023 ROI improved to 18.88 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ZTS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for ZTS's Competitors
Roi for Zoetis Inc's Suppliers
Return On Investment for ZTS's Customers

Other Ratios
ZTS's Roa ZTS's Inventory Turnover Ratio ZTS's Growth Rates ZTS's Dividend Statistics
ZTS's Profitability Ratios ZTS's Asset Turnover Ratio ZTS's Dividend Growth
ZTS's Roe ZTS's Valuation Ratios ZTS's Financial Strength Ratios ZTS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector ROI
Tevogen Bio Holdings Inc   51.46 %
Entrada Therapeutics Inc   50.42 %
Siga Technologies Inc  50.32 %
Dariohealth Corp   50.05 %
Protagonist Therapeutics inc   37.74 %
National Research Corporation  37.64 %
Pharmacyte Biotech Inc   37.58 %
Mettler Toledo International Inc  36.92 %
Medpace Holdings Inc   36.84 %
Idexx Laboratories Inc  36.50 %
Quince Therapeutics Inc   33.71 %
Exelixis Inc   32.02 %
Elite Pharmaceuticals Inc   31.13 %
Johnson and Johnson  30.31 %
Lantheus Holdings Inc   28.19 %
Carlisle Companies Incorporated  25.58 %
Tg Therapeutics Inc   25.31 %
Iradimed Corporation  23.13 %
Corcept Therapeutics Inc  23.12 %
Cardiff Lexington Corporation  22.21 %
Semler Scientific inc   21.17 %
Cassava Sciences Inc  20.29 %
Chemed Corporation  20.22 %
Kewaunee Scientific Corporation  19.98 %
Halozyme Therapeutics Inc   19.43 %
Eli Lilly And Company  19.05 %
Zoetis Inc   18.58 %
Merck and Co Inc   18.31 %
Insulet Corporation  18.09 %
United Therapeutics Corporation  17.70 %


Date modified: 2024-08-07T20:53:04+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com